ReviewCancer drug resistance (Alhambra, Calif.)2022

HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer.

Bernhard Biersack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.